Human papillomavirus prevalence and type distribution among women attending routine gynecological examinations in Saudi Arabia

Table 1 HPV prevalence and type distribution (N = 417)

N = 417	n	%	95% CI
HPV negative	376	90.2	86.9–92.9
HPV positive	41	9.8	7.1–13.1
Single infection	25	61.0	44.5–75.8
Multiple infection	4	9.8	2.7–23.1
Non-typeable^#	12	29.3	16.1–45.5
HPV-types (n = 41)*
Any high-risk HPV**	18	43.9	28.5–60.3
HPV-68/73	5	12.2	4.1–26.2
HPV-18	4	9.8	2.7–23.1
HPV-16	3	7.3	1.5–19.9
HPV-31	2	4.9	0.6–16.5
HPV-51	2	4.9	0.6–16.5
HPV-52	2	4.9	0.6–16.5
HPV-39	1	2.4	0.1–12.9
HPV-56	1	2.4	0.1–12.9
HPV-58	1	2.4	0.1–12.9
Any low-risk HPV***	14	34.1	20.1–50.6
HPV-6	4	9.8	2.7–23.1
HPV-42	2	4.9	0.6–16.5
HPV-53	2	4.9	0.6–16.5
HPV-54	2	4.9	0.6–16.5
HPV-11	1	2.4	0.1–12.9
HPV-40	1	2.4	0.1–12.9
HPV-70	1	2.4	0.1–12.9
HPV-74	1	2.4	0.1–12.9

N: number of women whose cervical samples were tested; n: number of women in a given category; 95% CI: exact 95% confidence interval.
^#DEIA positive-LiPA negative.
*Some women were infected with multiple HR/LR HPV types.
**Includes 14 women with single HR-HPV infection and 4 women with multiple infections and at least one HR-HPV type.
***Includes 11 women with single LR-HPV infection and 3 women with multiple infections and at least one LR-HPV type.
Note: Single infection = 25/417 = 6.0% (95% CI: 3.9–8.7); Multiple infection = 4/417 = 0.9% (95% CI: 0.3–2.4); non-typeable = 12/417 = 2.9% (95% CI: 1.5–5.0).

ISSN: 1471-2334